Gene Panel Market Size, Revenue, Forecast Report 2026 to 2035
Market Segmentation:
Gene Panel Market by Technique -
• Amplicon-Based
• Hybridization-Based
Gene Panel Market by Design-
• Predesigned Gene Panels
• Customized Gene Panels
Gene Panel Market by Application-
• Pharmacogenetics
• Diagnosis of Congenital Disorders
• Cancer Risk Assessment
• Others
Gene Panel Market by End User -
• Research and Academic Institutes
• Hospital and Diagnostic Laboratories
• Biotechnology and Pharmaceutical Companies
Gene Panel Market by Region-
North America-
• The US
• Canada
Europe-
• Germany
• UK
• France
• Nordics
• Netherlands
• Switzerland
• Spain
• Italy
• Benelux
• Rest of Europe
Asia-Pacific-
• China
• Japan
• South Korea
• Australia
• India
• Rest of APAC
Latin America-
• Brazil
• Mexico
• Chile
• Rest of LatAm
Middle East & Africa-
• GCC
• South Africa
• Rest of MEA
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Gene Panel Market Snapshot
Chapter 4. Global Gene Panel Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Trends
4.6. Gene Panel Technologies & Genomic Testing Analysis
4.7. Industry Standards & Regulatory Framework
4.8. Precision Medicine, Next-Generation Sequencing & Personalized Diagnostics Impact Analysis
4.9. Value Chain Analysis
4.10. Porter’s Five Forces Analysis
4.11. Competitive Landscape & Market Share Analysis
4.12. Market Attractiveness Analysis
Chapter 5. Gene Panel Market Segmentation 1: By Technique, Estimates & Trend Analysis
5.1. Market Share by Technique, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
5.2.1. Amplicon-Based
5.2.2. Hybridization-Based
Chapter 6. Gene Panel Market Segmentation 2: By Design, Estimates & Trend Analysis
6.1. Market Share by Design, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
6.2.1. Predesigned Gene Panels
6.2.2. Customized Gene Panels
Chapter 7. Gene Panel Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
7.2.1. Pharmacogenetics
7.2.2. Diagnosis of Congenital Disorders
7.2.3. Cancer Risk Assessment
7.2.4. Others
Chapter 8. Gene Panel Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
8.2.1. Research and Academic Institutes
8.2.2. Hospital and Diagnostic Laboratories
8.2.3. Biotechnology and Pharmaceutical Companies
Chapter 9. Gene Panel Market Segmentation 5: By Geography, Estimates & Trend Analysis
9.1. Market Share by Geography, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
9.2.1. North America
9.2.2. Europe
9.2.3. Asia-Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
Chapter 10. Gene Panel Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Gene Panel Market Regional Snapshot (2025 & 2035)
10.2. North America
10.2.1. North America Gene Panel Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. North America Gene Panel Market Revenue Estimates and Forecasts by Technique, 2022–2035
10.2.3. North America Gene Panel Market Revenue Estimates and Forecasts by Design, 2022–2035
10.2.4. North America Gene Panel Market Revenue Estimates and Forecasts by Application, 2022–2035
10.2.5. North America Gene Panel Market Revenue Estimates and Forecasts by End User, 2022–2035
10.3. Europe
10.3.1. Europe Gene Panel Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Gene Panel Market Revenue Estimates and Forecasts by Technique, 2022–2035
10.3.3. Europe Gene Panel Market Revenue Estimates and Forecasts by Design, 2022–2035
10.3.4. Europe Gene Panel Market Revenue Estimates and Forecasts by Application, 2022–2035
10.3.5. Europe Gene Panel Market Revenue Estimates and Forecasts by End User, 2022–2035
10.4. Asia Pacific
10.4.1. Asia Pacific Gene Panel Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.4.1.1. China
10.4.1.2. Japan
10.4.1.3. India
10.4.1.4. South Korea
10.4.1.5. Southeast Asia
10.4.1.6. Rest of Asia Pacific
10.4.2. Asia Pacific Gene Panel Market Revenue Estimates and Forecasts by Technique, 2022–2035
10.4.3. Asia Pacific Gene Panel Market Revenue Estimates and Forecasts by Design, 2022–2035
10.4.4. Asia Pacific Gene Panel Market Revenue Estimates and Forecasts by Application, 2022–2035
10.4.5. Asia Pacific Gene Panel Market Revenue Estimates and Forecasts by End User, 2022–2035
10.5. Latin America
10.5.1. Latin America Gene Panel Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.5.1.1. Brazil
10.5.1.2. Argentina
10.5.1.3. Mexico
10.5.1.4. Rest of Latin America
10.5.2. Latin America Gene Panel Market Revenue Estimates and Forecasts by Technique, 2022–2035
10.5.3. Latin America Gene Panel Market Revenue Estimates and Forecasts by Design, 2022–2035
10.5.4. Latin America Gene Panel Market Revenue Estimates and Forecasts by Application, 2022–2035
10.5.5. Latin America Gene Panel Market Revenue Estimates and Forecasts by End User, 2022–2035
10.6. Middle East & Africa
10.6.1. Middle East & Africa Gene Panel Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.6.1.1. GCC
10.6.1.2. South Africa
10.6.1.3. Rest of MEA
10.6.2. Middle East & Africa Gene Panel Market Revenue Estimates and Forecasts by Technique, 2022–2035
10.6.3. Middle East & Africa Gene Panel Market Revenue Estimates and Forecasts by Design, 2022–2035
10.6.4. Middle East & Africa Gene Panel Market Revenue Estimates and Forecasts by Application, 2022–2035
10.6.5. Middle East & Africa Gene Panel Market Revenue Estimates and Forecasts by End User, 2022–2035
Chapter 11. Competitive Landscape
11.1. Market Share Analysis — Top Players (2025)
11.2. Competitive Benchmarking
11.3. Major M&A, Partnerships, Product Launches & Technology Developments (2022–2026)
11.4. Company Profiles (14 Companies)
11.4.1. Thermo Fisher Scientific Inc.
11.4.3. Illumina, Inc.
11.4.4. QIAGEN N.V.
11.4.5. Agilent Technologies, Inc.
11.4.6. Danaher Corporation
11.4.7. Twist Bioscience Corporation
11.4.8. Labcorp Holdings Inc.
11.4.9. Myriad Genetics, Inc.
11.4.10. Roche Holding Ltd
11.4.11. Fulgent Genetics, Inc.
11.4.12. GeneDx Holdings Corp.
11.4.13. Personalis, Inc.
11.4.14. BGI Genomics Co., Ltd.
11.4.15. Novogene Co., Ltd.
11.4.16. Azenta, Inc.
11.4.17. Eurofins Scientific SE
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Gene Panel Market Size is valued at USD 49.96 Bn in 2025 and is predicted to reach USD 335.96 Bn by the year 2035
Gene Panel Market is expected to grow at a 21.2% CAGR during the forecast period for 2026 to 2035.
Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Personalis Inc., GeneDx Inc., Invitae Corporation.
Gene Panel Market is segmented into By Technique, Design, Application, End Users and By Region
North America region is leading the Gene Panel Market.